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Abstract
Population-level disease risk varies in space and time, and is typically estimated using aggre-
gated disease count data relating to a set of non-overlapping areal units for multiple consec-
utive time periods. A large research base of statistical models and corresponding software
has been developed for such data, with most analyses being undertaken in a Bayesian setting
using either Markov chain Monte Carlo (MCMC) simulation or integrated nested Laplace
approximations (INLA). This paper presents a tutorial for undertaking spatio-temporal dis-
ease modelling using MCMC simulation, utilising the CARBayesST package in the R software
environment. The tutorial describes the complete modelling journey, starting with data in-
put, wrangling and visualisation, before focusing on model fitting, model assessment and
results presentation. It is illustrated by a new case study of pneumonia mortality at the
local authority level in England, and answer important public health questions including the
effect of covariate risk factors, spatio-temporal trends, and health inequalities.
Keywords: Bayesian inference, CARBayesST, Spatio-temporal modelling
1. Introduction1
Population-level disease risk varies in space and time between sub-populations, due to vari-2
ation in environmental exposures and the prevalence of risk inducing behaviours such as3
∗Corresponding author - Duncan Lee, School of Mathematics and Statistics, University of Glasgow,
Glasgow, G12 8SQ
Email address: Duncan.Lee@glasgow.ac.uk (Duncan Lee )
Preprint submitted to Spatial and Spatio-Temporal Epidemiology April 8, 2020
smoking. Estimating the spatio-temporal variation in disease risk is an important endeavour4
for researchers and policy-makers alike, because it allows them to answer important public5
health questions such as: (i) where are the highest-risk areas for disease that can be targeted6
for an intervention; (ii) is disease risk increasing or decreasing over time; (iii) how big are7
the health inequalities, and are they changing over time; and (iv) what environmental or8
social factors affect the risk of disease. In the above, health inequalities are the differences9
in disease risk between different communities (World Health Organisation, 2013) and are10
often driven by poverty, with poorer populations typically exhibiting higher disease risks11
than more affluent populations.12
Data summarising population level disease incidence are commonly used to answer these13
questions, which have been spatio-temporally aggregated to a set of K non-overlapping areal14
units for N consecutive time intervals. These data thus comprise a K ×N matrix of spatio-15
temporal observed disease counts, which are augmented by matrices of expected counts16
computed using indirect standardisation to allow for varying population demographics, and17
covariate risk factors. A large number of models have been developed for estimating the18
spatio-temporal variation in disease risk, and comprehensive reviews are given by Lawson19
and Lee (2017) and Lawson (2018). The class of conditional autoregressive (CAR, Besag20
et al., 1991) models are commonly used to represent the spatially correlated variation in21
disease risk, and are used as a prior distribution for a set of spatially structured random22
effects. Spatio-temporal extensions of CAR models have been proposed by numerous authors,23
including Bernardinelli et al. (1995), Knorr-Held (2000) and Rushworth et al. (2014). These24
models assume that disease risk varies smoothly in space and time, and thus account for the25
inherent spatio-temporal autocorrelation typically observed amongst the disease data. A26
Bayesian approach to inference is typically adopted, using either Markov chain Monte Carlo27
(MCMC, Robert and Casella, 2010) simulation or Integrated Nested Laplace Approximations28
(INLA, Rue et al., 2009)).29
A number of software packages have been developed to allow researchers to fit spatio-30
temporal conditional autoregressive type models in a Bayesian setting, including WinBUGS31
(Lunn et al., 2000) and STAN (Morris et al., 2019). However, these packages can be dif-32
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ficult to use for novice users, and also lack the ability to undertake additional analyses,33
such as data visualisation and wrangling, within the same software environment. Therefore34
the R software environment (https://cran.r-project.org) has a number of packages for35
spatio-temporal areal unit modelling, including the INLA package (Martins et al., 2013) using36
integrated nested Laplace approximations, and CARBayes (spatial modelling, Lee, 2013) and37
CARBayesST (spatio-temporal modelling, Lee et al., 2018) both using MCMC simulation.38
Both INLA and CARBayes / CARBayesST can fit a range of different spatio-temporal disease39
risk models for areal unit data, while INLA can also model geostatistical (Lindgren et al.,40
2011) and point process (Illian et al., 2012) spatio-temporal data. The main advantage of41
INLA is computational speed, because it uses Laplace approximations to estimate the pos-42
terior distribution of the unknown parameters, rather than drawing repeated samples from43
the posterior distribution as MCMC does. In contrast, while slower than INLA, CARBayesST44
is potentially easier to use for novice users, because: (i) all models can be implemented via a45
simple one-line function call requiring the user to specify few arguments for a default anal-46
ysis, even when specifying the spatio-temporal data structures; and (ii) important epidemi-47
ological quantities such as posterior exceedance probabilities are straightforward to produce48
because you have direct access to samples from the posterior risk distribution. Additionally,49
CARBayeST allows users to fit localised spatial autocorrelation models such as that proposed50
by Rushworth et al. (2017), which is not possible using the INLA package. These localised51
correlation models recognise that disease risk in geographically adjacent areal units may not52
always be similar (correlated), which stems from the seminal work of Womble (1951).53
Excellent tutorials for how to use the INLA package for spatio-temporal modelling have54
been written by Blangiardo et al. (2013) and Moraga (2018), but no such tutorial exists for55
spatio-temporal modelling with CARBayesST using MCMC simulation. Therefore this paper56
fills that gap, and presents a tutorial describing how to undertake spatio-temporal Bayesian57
areal unit modelling via MCMC simulation using the CARBayesST package. Lee et al. (2018)58
provides a general vignette for the CARBayesST software including a description of the suite59
of models that the package can fit, where as here we provide a specific tutorial on spatio-60
temporal disease risk modelling aimed at applied public health researchers. We also note61
that the purely spatial modelling package CARBayes has an identical syntax to CARBayesST,62
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and hence will be straightforward to use following a similar approach to that described here.63
This tutorial is illustrated by a new study of pneumonia mortality in England at the local64
authority level. The data and the questions motivating the analysis are described in Section65
2, while exploratory analysis is presented in Section 3. Spatio-temporal model fitting and66
model assessment is outlined in Section 4, while the results of the analysis are presented in67
Section 5. Finally, this tutorial finishes with an outline of future developments in Section 6.68
The data, shapefiles and R code used in this tutorial are available to download from https:69
//github.com/duncanplee/Spatio-temporal-modelling-tutorials, which also includes70
a video tutorial illustrating the analysis presented here.71
2. Motivating study72
The study region is mainland England, which has a population of around 55 million people73
and has been partitioned intoK = 322 local authorities. Data are available at yearly intervals74
between 2002 to 2017 inclusive, yielding N = 16 time periods. The disease data {Ykt} are75
counts of the numbers of pneumonia mortalities (International Classification of disease ICD-76
10 codes J12-J18) in local authority k during year t, and were obtained from NHS digital77
https://digital.nhs.uk/. These counts vary between 10 and 680 in each local authority78
and year, with a median value of 75. The local authorities have different population sizes79
and demographic structures, and indirect standardisation is used to account for the fact80
that areas with larger and more elderly populations are likely to exhibit more mortalities.81
Specifically, the population in local authority k during year t is split into R strata based on82
age and sex (e.g. females 0-4, females 5-9, etc.), and nktr denotes the number of people in83
strata r. These strata specific population sizes nktr are multiplied by national strata specific84
pneumonia mortality rates γr averaged over the study period 2002-2107, and the results are85
summed over strata to give the expected number of pneumonia mortalities in local authority86






and represent the number of mortalities expected if national age and sex specific pneumonia88
mortality rates averaged over 2002-2017 applied to local authority k during year t. Ad-89
ditionally, we also have two covariates that may explain the spatio-temporal variation in90
pneumonia mortality risk, the first of which is a proxy measure of socio-economic depriva-91
tion (poverty). Socio-economic deprivation is well known to affect morbidity and mortality,92
and is one of the main drivers of health inequalities (World Health Organisation, 2013). In93
this study we have access to the English Index of multiple deprivation (IMD, Department for94
Communities and Local Government, 2015) in 2015, which for local authority k is denoted95
by IMDk. The IMD is a composite index of deprivation comprising data from 7 different96
domains, including: barriers to housing, crime, education, employment, health, income and97
living environment. As the calculation of the index changes from one year to the next, we98
only use data for one year, meaning this covariate will only capture the spatial variation in99
disease risk.100
The other covariate we have is a measure of fine particulate matter air pollution known as101
PM2.5 (measured in µgm−3), which is a mixture of solid and liquid particles in the air that102
are less than 2.5 micrometres in diameter. Measured concentrations of PM2.5 are available103
from https://uk-air.defra.gov.uk, but the network of monitors is not dense at the local104
authority level required for this study. Therefore instead we utilise annual average mod-105
elled concentrations from the Pollution Climate Mapping (PCM) model developed for the106
Department for the Environment, Food and Rural Affairs (DEFRA), which are freely avail-107
able from https://uk-air.defra.gov.uk/data/pcm-data. The model estimates annual108
average PM2.5 concentrations on a 1km2 square grid, which need to be spatially realigned109
with the irregularly shaped local authorities. This is achieved by computing the average110







where the average is taken over all grid squares whose centroid gi lies within local authority112
Ak. In the above equation qk denotes the number of grid square centroids that lie within113
the kth local authority Ak, while PM25it denotes the annual average concentration of PM2.5114
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for year t and grid square with centroid gi. Our aim in analysing these data is to answer 3115
key questions of public health importance, which are:116
1. What effects do the air pollution and socio-economic covariates have on disease risk?117
2. What is the temporal trend in disease risk and which local authorities exhibit the118
highest risks of disease?119
3. How big are the health inequalities in pneumonia mortality risk across England, and120
are these inequalities increasing or decreasing over time?121
3. Exploratory analysis122
3.1. Reading in and visualising the spatio-temporal trends in the data123
The disease and covariate data are stored in EnglandLUAdata.csv, which has a unique local124
authority code (Code) and year (Year) combination for each row of the data set. The local125
authority code is accompanied by the name of local authority (Name), and the remaining126
4 variables were described in the previous section. The data can be read into R and the127
variable names visualised using the following commands.128
dat <- read.csv(file="EnglandLUAdata.csv")
head(dat, n=3)
## Code Name Year Y E PM25 IMD129
## 1 00AB Barking and Dagenham LB 2002 145 78.04092 11.23563 34.635130
## 2 00AB Barking and Dagenham LB 2003 210 75.89981 16.92847 34.635131
## 3 00AB Barking and Dagenham LB 2004 130 75.55028 16.70258 34.635132
Note, it is simplest in practice to put the data in the same folder as the R script file you are133
writing your analysis in, and then in Rstudio setting the working directory to the location134
of the source file. The first step in an exploratory analysis of these data is to compute the135
standardised mortality ratio (SMR) for each local authority and year combination to measure136
the mortality risk, which is computed by dividing the observed number of mortalities (Y) by137
the expected number of mortalities (E). It is added to the data set using the dplyr package138





























Figure 1: Scatterplots displaying the relationships between each covariate and the SMR.
library(dplyr)
dat <- dat %>% mutate(SMR=dat$Y/dat$E)
If the SMR equals 1 the observed and expected mortality counts are equal which represents140
an average risk area relative to the entire study region, while an SMR greater than 1 denotes141
a high risk area. For example, an SMR of 1.2 corresponds to a 20% increased risk compared142
to the English national average over the 16 year study period. Similarly an SMR of 0.9143
corresponds to a 10% decreased risk compared to the national average. The relationship be-144
tween the SMR and the two covariates can be visualised via scatterplots (Figure 1) using the145




The figure shows there are low to medium correlations between the SMR and the two covari-148
ates, suggesting that the latter might be significant predictors of disease risk. Visualising149









Figure 2: Boxplots displaying the temporal trend in the SMR.
motivating question for this analysis, and the temporal trend in disease risk can be visualised151
via boxplots of the SMR for each year (Figure 2) using the code below.152
library(ggplot2)
ggplot(dat, aes(x = factor(Year), y = SMR)) +
geom_boxplot(fill="red", alpha=0.7) +
scale_x_discrete(name = "Year", breaks=c(2002, 2005, 2008, 2011, 2014, 2017),
labels=c("2002", "2005", "2008", "2011", "2014", "2017")) +
scale_y_continuous(name = "SMR") +
theme(text=element_text(size=16), plot.title=element_text(size=18, face="bold"))
The figure shows that the SMR appears to decrease substantially over time, and is lowest in153
the final year of 2017 compared to any of the preceding years. The magnitude of the health154
inequalities also appears to have decreased, as there is markedly less variation in disease risk155
(the boxplots are narrower) in the later years. To view the average spatial pattern in the156
SMR we first need to read the shapefiles containing the local authority boundaries into R,157
which can be done using functionality of the rgdal package as shown below.158
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library(rgdal)
LA <- readOGR(dsn = "LocalAuthorities.shp")
Then the average SMR for each local authority can be computed via the code below.159
by_LA <- group_by(dat, Code)
averageSMR <- summarize(by_LA, SMR = mean(SMR, na.rm=T))
This new data set averageSMR then needs to be combined with the local authority boundaries160
via161
averageSMR.LA <- merge(x=LA, y=averageSMR, by.x="lad09cd", by.y="Code", all.x=FALSE)
which gives a SpatialPolygonsDataFrame object. The SMR variable can then be super-162
imposed onto an OpenStreetMap using functionality from the leaflet package, and the163
resulting map is displayed in Figure 3.164
library(leaflet)
averageSMR.LA <- merge(x=LA, y=averageSMR, by.x="lad09cd", by.y="Code", all.x=FALSE)
averageSMR.LA.ll <- spTransform(averageSMR.LA, CRS("+proj=longlat +datum=WGS84 +no_defs"))
variable <- averageSMR.LA.ll@data$SMR
colours <- colorNumeric(palette = "YlOrBr", domain = variable, reverse=FALSE)
leaflet(data=averageSMR.LA.ll) %>%
addTiles() %>%
addPolygons(fillColor = ˜colours(variable), color="", fillOpacity = 0.7,
weight = 1, smoothFactor = 0.5, opacity = 1.0) %>%
addLegend(pal = colours, values = variable, opacity = 1, title="SMR") %>%
addScaleBar(position="bottomleft")
The second line of the code above transforms the coordinate reference system of the165
averageSMR.LA object to longitude and latitude to be compatible with OpenStreetMap.166
The map shows that the main clusters of high risk local authorities are around the north167
west urban communities of Liverpool, Manchester and Sheffield, while lower risk areas are168
generally rural169
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Figure 3: Spatial map of the average SMR between 2002 and 2017.
3.2. Naive regression modelling ignoring spatio-temporal autocorrelation170
Before incorporating spatio-temporally autocorrelated random effects into the model, one171
should check whether the available covariates capture all of the spatio-temporal autocorre-172
lation in the disease data. Thus a simple initial model is a Poisson log-linear model, which173
for our data is given by174
Ykt ∼ Poisson(Ektθkt) for k = 1, . . . , K, t = 1, . . . , N (3)
ln(θkt) = β0 + β1IMDk + β2PM25kt,
where θkt is the risk of disease in local authority k during year t relative to the expected counts175
Ekt, and is on the same scale as the SMR. This model can be fitted using maximum likelihood176
estimation via the glm() function, or in a Bayesian setting using MCMC simulation using177
the function S.glm() within the CARBayes package. Here we adopt the former approach for178
simplicity, and fit the above model as shown below:179
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model1 <- glm(formula=Y˜offset(log(E)) + IMD + PM25, family="poisson", data=dat)
round(cbind(model1$coefficients, confint(model1)),4)
## 2.5 % 97.5 %180
## (Intercept) -0.6529 -0.6681 -0.6377181
## IMD 0.0082 0.0079 0.0086182
## PM25 0.0443 0.0430 0.0455183
From the point estimates and 95% confidence intervals both covariates initially exhibit signifi-184
cant effects on pneumonia mortality risk, with increasing levels of socio-economic deprivation185
and air pollution being associated with an increased risk. To check for the presence of spatial186
autocorrelation we first add the residuals from this simple model to the data set and then187
extract the residuals for a single year. We illustrate this process for 2010, where the last line188
transforms the residuals into a SpatialPolygonsDataFrame object.189
dat$residuals <- residuals(model1)
residuals2010 <- filter(dat, Year==2010)
residuals2010.LA <- merge(x=LA, y=residuals2010, by.x="lad09cd", by.y="Code", all.x=FALSE)
A commonly used measure of spatial autocorrelation is Moran’s I statistic (Moran, 1950),190













where rk denotes the residual for the kth local authority. Additionally, W = (wkj) is a K×K192
neighbourhood or adjacency matrix, which denotes whether each pair of local authorities are193
close together. Typically a binary specification is taken, where wkj = 1 if local authorities194
(k, j) share a common border, and wkj = 0 otherwise. Other specifications are possible,195
and a review is given by Earnest et al. (2007). The value of Moran’s I statistic lies between196
(-1,1), with a value of zero corresponding to spatial independence while a value of 1 denotes197
strong positive spatial autocorrelation. Before computing this statistic the neighbourhood198
matrix W needs to be constructed using the following code.199
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library(spdep)
W.nb <- poly2nb(residuals2010.LA, row.names = residuals2010.LA@data$lad09cd)
W <- nb2mat(W.nb, style = "B")
W.list <- nb2listw(W.nb, style = "B")
The neighbourhood matrix is the W object, while the W.list object is a list type variant of this200
object required in the computation of Moran’s I. Further details on the construction of these201
objects and other alternatives are available from Bivand et al. (2013) and the spdep package.202
A permutation test with the null hypothesis of spatial independence can be conducted based203
on Moran’s I statistic using the following code, where the p-value is based on 10,000 random204
permutations of the data.205
moran.mc(x = residuals2010.LA$residuals, listw = W.list, nsim = 10000)




## number of simulations + 1: 10001210
##211
## statistic =0.27104, observed rank = 10001, p-value = 9.999e-05212
## alternative hypothesis: greater213
The test shows strong residual spatial autocorrelation, with a Moran’s I value of 0.271 and214
a p-value much less than 0.05. One could now assess the presence of residual temporal215
autocorrelation using the acf() function, but with only N = 16 time periods the results216
would not be that reliable and hence we don’t do that here.217
4. Bayesian spatio-temporal modelling using MCMC simulation218
As summarised in the introduction, a large number of models have been proposed for esti-219
mating the spatio-temporal trends in disease risk, and as our disease outcome variable is a220
count, they have the general form221
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Ykt ∼ Poisson(Ektθkt) for k = 1, . . . , K, t = 1, . . . , N (5)
ln(θkt) = β0 + β1IMDk + β2PM25kt + ψkt,
where ψkt is the random effect for local authority k and time period t. The regression222
parameters are typically assigned independent and weakly informative normal priors, and223
the default prior specification in CARBayesST is βj ∼ N(0, 100000). While independent224
normal priors are enforced for each βj in the software, the prior mean and variance can be225
changed using the arguments prior.mean.beta, prior.var.beta in the function call when226
fitting the model, see the individual helpfiles for more details.227
The spatio-temporal structure of the random effects {ψkt} depends on the goal of the analysis,228
and 3 commonly used models are outlined below.229
• Correlated linear time trends - ψkt = β1 + φk + (α + δk)(t − t̄)/N , where t̄ =230
(1/N)∑Nt=1 t, so that the time trend (t− t̄)/N runs over a centred unit interval. Addi-231
tionally, {φk} and {δk} are sets of spatially autocorrelated random effects, which allow232
the linear temporal trends to have spatially varying intercepts and slopes. This model233
was originally proposed by Bernardinelli et al. (1995), and is available in CARBayesST234
via the ST.CARlinear() function.235
• Spatio-temporal main effects and an interaction - ψkt = φk + δt + γkt, where236
{φk} and {δt} are respectively sets of spatially and temporally autocorrelated random237
effects, while {γkt} are space-time interactions. This model was originally proposed by238
Knorr-Held (2000), and is available in CARBayesST via the ST.CARanova() function.239
• Spatially autocorrelated first-order autoregressive process - ψt = ρTψt−1 +εt,240
whereψt = (ψ1t, . . . , ψKt) denotes the vector of random effects for all areal units at time241
t, and the vector of errors εt = (ε1t, . . . , εKt) is modelled as spatially autocorrelated.242
This model was used by Rushworth et al. (2014), and is available in CARBayesST via243
the ST.CARar() function.244
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In this tutorial the aim is to quantify the evolution of the spatial pattern in disease risk over245
time, so we use the spatially autocorrelated first-order autoregressive process model given by246
ψt = ρTψt−1+εt. Temporal autocorrelation is controlled by the mean function ρTψt−1, while247
spatial autocorrelation is controlled by the covariance structure of εt. The latter is modelled248
as spatially autocorrelated and given by εt ∼ N(0, τ 2Q(W, ρS)−1), where τ 2 is the process249
variance. The precision matrix is given by Q(W, ρS) = ρS(diag[W1] −W) + (1 − ρS)I,250
where (1, I) are a K × 1 vector of ones and the K ×K identity matrix respectively Spatial251
autocorrelation is induced by the neighbourhood matrix W defined above, and if wkj = 1252
then the random errors (εkt, εjt) are modelled as spatially autocorrelated, while if wkj =253
0 then (εkt, εjt) are assumed to be conditionally independent. Thus (ρS, ρT ) respectively254
control the levels of spatial and temporal autocorrelation, with values of 0 corresponding to255
independence while a value of 1 corresponds to strong autocorrelation. The precision matrix256
Q(W, ρS) corresponds to the conditional autoregressive (CAR) prior proposed by Leroux257













j=1 wkj + 1− ρS
)
, (6)
τ 2 ∼ Inverse-Gamma(1, 0.01),
ρS, ρT ∼ Uniform(0, 1),
where the last 2 lines give weakly informative priors for the remaining parameters and259
ε−kt = (ε1t, . . . , εk−1t, εk+1t, . . . , εKt). Whilst the default prior specification for τ 2 is τ 2 ∼260
Inverse-Gamma(1, 0.01), the hyperparameters (1, 0.01) can be changed by the user via the261
prior.tau2 argument in the function call when fitting the model, see the helpfile for262
ST.CARar() for more details. If ρS = 1 the model simplifies to the intrinsic CAR prior263
proposed Besag et al. (1991), while if ρS = 0 the errors εkt are independent with mean zero264
and a constant variance τ 2, i.e. εkt ∼ N(0, τ 2).265
Before fitting this model one must re-order the data in dat, because the software CARBayesST266
requires the data to be ordered so that the first K data points relate to all the spatial units267
for time period 1, the next K data points relate to all the spatial units for time period 2268
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and so on. Additionally, the spatial units must be ordered in the same way as specified by269
the neighbourhood matrix W. These ordering constraints can be implemented using the code270
below, which first creates a spatial ordering identifier (spatialorder) and then arranges the271
data by that identifier.272
lookup <- data.frame(Code=residuals2010.LA@data$lad09cd,
spatialorder=1:nrow(residuals2010.LA@data))
dat.temp <- merge(x=dat, y=lookup, by="Code")
dat.ordered <- arrange(dat.temp, Year, spatialorder)
The model can then be fitted to the ordered data using MCMC simulation via the273
ST.CARar() function using the code below.274
library(CARBayesST)
chain1 <- ST.CARar(formula=Y˜offset(log(E)) + PM25 + IMD, family="poisson",
data=dat.ordered, W=W, burnin=200000, n.sample=2200000, thin=1000, verbose=FALSE)
chain2 <- ST.CARar(formula=Y˜offset(log(E)) + PM25 + IMD, family="poisson",
data=dat.ordered, W=W, burnin=200000, n.sample=2200000, thin=1000, verbose=FALSE)
chain3 <- ST.CARar(formula=Y˜offset(log(E)) + PM25 + IMD, family="poisson",
data=dat.ordered, W=W, burnin=200000, n.sample=2200000, thin=1000, verbose=FALSE)
The above code runs the model 3 times to generate MCMC samples from 3 independent275
Markov chains. Each chain is run for 2,200,000 samples (n.sample), of which 200,000 are276
removed as the burnin period (burnin) and the remaining 2,000,000 samples are thinned277
by 1,000 (thin) to remove almost all of the correlation amongst the samples. This leaves278
6,000 samples for inference overall, with 2,000 coming from each chain. The first step is279
to assess whether the Markov chains have converged, which can be done in numerous ways.280
The simplest check is to draw a traceplot of the samples for each parameter, and convergence281
is indicated if the samples show no trend in their means or variances. As an example, trace282
plots for the regression parameters β = (β0, β1, β2) for all 3 chains can be produced using283
the following code, and are shown in Figure 4.284
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N = 2000   Bandwidth = 0.0001476
Figure 4: Traceplots of the MCMC samples from each chain.
library(coda)
beta.samples <- mcmc.list(chain1$samples$beta, chain2$samples$beta, chain3$samples$beta)
plot(beta.samples)
The figure shows the chains appear to have converged, as there is no change in the mean or285
variance of the samples between the three chains. An additional check is the Gelman-Rubin286
diagnostic (Gelman et al., 2013), which uses the between to within chain variation in the287
MCMC samples to quantify the potential scale reduction that might be achieved if we run288
the MCMC chains for longer. Gelman et al. (2013) recommend that a value less than 1.1289
indicates good mixing of the chain, and the Gelman-Rubin statistic for each chain separately290
and then jointly for all chains is computed using the code below.291
gelman.diag(beta.samples)
## Potential scale reduction factors:292
##293
16
## Point est. Upper C.I.294
## [1,] 1 1.01295
## [2,] 1 1.01296





The results shows that the samples appear to be well mixed, which again indicates that302
one can proceed with inference from this model. Note, in principle these diagnostic checks303
should be applied to every parameter, but due to the large number of random effects this304
is infeasible in practice. Therefore a pragmatic strategy is to undertake these checks for305
(β, τ 2, ρS, ρT ) and a sample of the spatio-temporal random effects {ψkt}. The results from306





## #### Model fitted311
## #################312
## Likelihood model - Poisson (log link function)313
## Latent structure model - Autoregressive CAR model314





## Posterior quantities for selected parameters and DIC320
##321
## Median 2.5% 97.5% n.effective Geweke.diag322
## (Intercept) -0.2601 -0.3746 -0.1409 1165.9 -1.2323
## PM25 0.0033 -0.0082 0.0148 1154.0 0.9324
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## IMD 0.0098 0.0082 0.0114 1577.7 0.8325
## tau2 0.0252 0.0226 0.0280 2000.0 0.7326
## rho.S 0.9922 0.9855 0.9961 2000.0 1.1327
## rho.T 0.8795 0.8586 0.8991 1858.5 -0.9328
##329
## DIC = 39345.94 p.d = 1869.179 LMPL = -20003.09330
The output provides a description of the model at the top, and model fit criteria such as the331
deviance information criterion (DIC, Spiegelhalter et al., 2002)) at the bottom. The middle332
table of resuts presents parameter summaries, including the posterior median point estimate333
(Median) and 95% credible intervals (2.5%, 97.5%). The n.effective column estimates the334
effective number of independent samples, and the Geweke.diag gives the Geweke diagnostic335
(Geweke, 1992), another MCMC convergence diagnostic that should lie between -2 and 2 to336
indicate convergence.337
5. Inference from the model338
We now answer the three questions of interest motivating the analysis posed in Section 2.339
Firstly, the effects of IMD and PM25 on pneumonia mortality risk are quantified as relative340
risks, for a fixed increase ξ in each covariates value. For example, the relative risk for a ξ341
increase in IMD is computed by342
RR(IMD, ξ) = Risk of disease if IMD increased by ψRisk of disease given the current value of IMD (7)
= exp(β0 + β1(IMDk + ξ) + β2PM25kt + ψkt)exp(β0 + β1IMDk + β2PM25kt + ψkt)
= exp(β1ξ).
Here we use the standard deviation of each covariate as the increase ξ, because they represent343
realistic increases in each covariates value. These increases are 2.26µgm−3 for PM25 and 8.02344
for IMD. To compute these relative risks we first construct a matrix of the MCMC samples for345
the regression parameters (β1, β2) from all chains, and then compute the estimated relative346
risks as shown below.347
18
beta.samples.combined <- rbind(chain1$samples$beta[ ,2:3], chain2$samples$beta[ ,2:3],
chain3$samples$beta[ ,2:3])
round(quantile(exp(sd(dat.ordered$PM25) * beta.samples.combined[ ,1]), c(0.5, 0.025, 0.975)),3)
## 50% 2.5% 97.5%348
## 1.007 0.982 1.033349
round(quantile(exp(sd(dat.ordered$IMD) * beta.samples.combined[ ,2]), c(0.5, 0.025, 0.975)),3)
## 50% 2.5% 97.5%350
## 1.082 1.068 1.095351
The results show that the posterior median relative risk for PM25 is close to 1, and that PM25352
is not significantly related to pneumonia mortality risk as the 95% credible interval contains353
the null risk of 1. In contrast, the index of multiple deprivation IMD is significantly related to354
pneumonia mortality risk, with a 95% credible interval that is wholly above 1. The posterior355
median relative risk is 1.082, which suggests that if IMD increases by 8.02 then the risk of356
pneumonia mortality increases by 8.2%.357
The remaining questions of interest concern the spatio-temporal trends in disease risk {θkt},358
and the posterior risk distributions for each local authority and year are created by the code359
below, which divides the samples of fitted values {E(Ykt) = Ektθkt} by the fixed expected360
numbers of disease cases {Ekt}.361




risk.samples.combined <- fitted.samples.combined /
matrix(rep(dat.ordered$E, n.samples), nrow=n.samples, ncol=n.all, byrow=TRUE)
Each column of risk.samples.combined contains the posterior samples for θkt for a single362
local authority and time period, and the columns are ordered in the same way as the rows363
of data.ordered. To estimate the average temporal trend to answer the second motivating364
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question, the first step is to estimate the average (mean) risk across the K = 322 local365
authorities for each year and MCMC sample, yielding the posterior distribution of these366
spatial averages for each year. This averaging is carried out by the code below.367
N <- length(table(dat.ordered$Year))
risk.trends <- array(NA, c(n.samples, N))
for(i in 1:n.samples)
{
risk.trends[i, ] <- tapply(risk.samples.combined[i, ], dat.ordered$Year, mean)
}
Then the posterior median and 95% credible intervals can be computed for the spatially368
averaged risk as follows.369
time.trends <- as.data.frame(t(apply(risk.trends, 2, quantile, c(0.5, 0.025, 0.975))))
time.trends <- time.trends %>% mutate(Year=names(table(dat.ordered$Year)))
colnames(time.trends)[1:3] <- c("Median","LCI", "UCI")
Then finally the estimated temporal trend in disease risk can be plotted as shown below,370
and is displayed in Figure 5.371
ggplot(time.trends, aes(x = factor(Year), y = Median, group=1)) +
geom_line(col="red") +
geom_line(aes(x=factor(Year), y=LCI), col="red", lty=2) +
geom_line(aes(x=factor(Year), y=UCI), col="red", lty=2) +
scale_x_discrete(name = "Year", breaks=c(2002, 2005, 2008, 2011, 2014, 2017),
labels=c("2002", "2005", "2008", "2011", "2014", "2017")) +
scale_y_continuous(name = "Risk") +
theme(text=element_text(size=16), plot.title=element_text(size=18, face="bold"))
The figure shows a clear downward trend in pneumonia mortality risk over the 16 year study372
period, which appears to flatten out from around 2014 onwards. We display the spatial373
pattern in disease risk in two ways, the first being the posterior median risk surface θ̂kt. The374
second is the posterior exceedance probabilities (PEP), which are given by375












Figure 5: Posterior median and 95% credible interval for the temporal trend in disease risk.
the posterior probability that disease risk θkt is greater than one given the data Y, where a376
risk of one is the average risk across England over the 16 year study duration. We illustrate377
the computation of both these quantities (median risk and PEP) for 2010 as follows:378
risk.samples.2010 <- risk.samples.combined[ ,dat.ordered$Year==2010]
risk.2010 <- apply(risk.samples.2010, 2, median)
pep.2010 <- apply(risk.samples.2010 > 1, 2, mean)
Then, both quantities are added to the SpatialPolygonsDataFrame data set residuals2010.LA379
for mapping as follows.380
residuals2010.LA$risk.2010 <- risk.2010
residuals2010.LA$pep.2010 <- pep.2010
The maps of the median risk and the PEP for 2010 are displayed in Figure 6, and were381
generated with similar code to that used to create Figure 3 which is hence not shown for382
brevity. The posterior median risk map (left) shows that the risks are highest in the north-383
west of England close to the cities of Liverpool, Manchester and Sheffield, while low-risk384
areas are generally the larger and more rural local authorities. The PEP map (right) shows385
that a substantial number of rural local authorities have a zero probability of exceeding a386
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Figure 6: Estimated (posterior median) risk surface for 2010 (left) and the posterior exceedance probabilities
that that risk in 2010 is greater than 1 (right).
risk of one, while the probabilities for the urban areas, particularly in the north are much387
greater.388
Finally, the third motivating question concerns health inequalities, and here we focus on total389
inequality (World Health Organisation, 2013), which measures the variation in disease risk390
over the study region. We quantify this variation by the interquartile range (IQR) separately391
for each year, which measures the difference between the third and first quartiles of disease392
risks for a given year. These IQRs are computed for each year as shown below.393
risk.median <- apply(risk.samples.combined, 2, median)
inequality <- tapply(risk.median, dat.ordered$Year, IQR)
The temporal trend in these IQRs are displayed in Figure 7, and the code for creating this394
figure is not shown as it is similar to that used to create Figure 5. The figure shows that total395
inequality in pneumonia mortality risk, as measured by the IQR, has reduced by around a396
half, with values around 0.3 in 2002 compared to around 0.16 in 2017. This suggests that397












Figure 7: Estimated temporal trend in the health inequality in pneumonia mortality risk as measured by
the spatial interquartile range.
even in terms of risk in later years.399
6. Conclusions400
In this tutorial we have illustrated how to analyse spatio-temporal areal unit data using the401
CARBayesST package in R, which fits models in a Bayesian setting via MCMC simulation. The402
worked example on pneumonia mortality in England describes a complete spatio-temporal403
analysis, beginning with data input, wrangling and visualisation, and then modelling and404
drawing inference from the fitted model to answer epidemiologically important questions.405
The package allows the estimation of disease risk trends in both space and time, and the406
sister package CARBayes (Lee, 2013) allows purely spatial data to be modelled in a similar407
way.408
There are two main areas for future work in this software field, the first being the extension409
of the class of models and data structures that can be handled by these packages. While410
CARBayes has limited capability for modelling multivariate disease data, there is currently411
no capability for modelling multivariate areal unit data structured in space and time. The412
development of such models is a research priority due to the increasing availability of data413
on multiple diseases at the same spatio-temporal resolution. The second area for future414
development is the creation of an easy-to-use point-and-click user interface for the CARBayes /415
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CARBayesST family of software, because as the worked example in this tutorial demonstrates,416
modelling of such data requires a certain level of knowledge in R which may not be available417
to all applied researchers.418
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